The Manufacturers Life Insurance Company lowered its position in shares of Rockwell Medical, Inc. (NASDAQ:RMTI) by 0.5% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 38,908 shares of the company’s stock after selling 194 shares during the quarter. The Manufacturers Life Insurance Company owned 0.08% of Rockwell Medical worth $308,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of RMTI. Vanguard Group Inc. boosted its holdings in shares of Rockwell Medical by 4.9% in the first quarter. Vanguard Group Inc. now owns 1,990,057 shares of the company’s stock valued at $12,458,000 after buying an additional 93,589 shares during the period. Geode Capital Management LLC boosted its holdings in shares of Rockwell Medical by 9.7% in the first quarter. Geode Capital Management LLC now owns 371,700 shares of the company’s stock valued at $2,326,000 after buying an additional 32,964 shares during the period. KCG Holdings Inc. acquired a new position in shares of Rockwell Medical in the first quarter valued at approximately $111,000. Metropolitan Life Insurance Co. NY boosted its holdings in shares of Rockwell Medical by 11.3% in the first quarter. Metropolitan Life Insurance Co. NY now owns 42,220 shares of the company’s stock valued at $264,000 after buying an additional 4,287 shares during the period. Finally, Cutter & CO Brokerage Inc. boosted its holdings in shares of Rockwell Medical by 6.3% in the second quarter. Cutter & CO Brokerage Inc. now owns 25,325 shares of the company’s stock valued at $201,000 after buying an additional 1,500 shares during the period. Hedge funds and other institutional investors own 21.30% of the company’s stock.

Shares of Rockwell Medical, Inc. (NASDAQ RMTI) opened at $5.99 on Monday. Rockwell Medical, Inc. has a 1 year low of $5.06 and a 1 year high of $8.98.

Rockwell Medical (NASDAQ:RMTI) last announced its quarterly earnings data on Wednesday, November 8th. The company reported ($0.10) EPS for the quarter, hitting the Zacks’ consensus estimate of ($0.10). The business had revenue of $14.63 million for the quarter, compared to analyst estimates of $13.33 million. Rockwell Medical had a negative net margin of 39.28% and a negative return on equity of 46.63%. The firm’s revenue for the quarter was up 14.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.09) earnings per share. equities analysts predict that Rockwell Medical, Inc. will post -0.44 earnings per share for the current fiscal year.

Several research analysts have recently weighed in on RMTI shares. Zacks Investment Research upgraded shares of Rockwell Medical from a “hold” rating to a “buy” rating and set a $7.50 price target for the company in a report on Wednesday, October 25th. BidaskClub raised shares of Rockwell Medical from a “sell” rating to a “hold” rating in a research report on Wednesday, August 23rd. Finally, Ifs Securities initiated coverage on shares of Rockwell Medical in a research report on Monday, August 14th. They issued a “strong-buy” rating and a $11.00 price objective on the stock.

TRADEMARK VIOLATION WARNING: “The Manufacturers Life Insurance Company Has $308,000 Position in Rockwell Medical, Inc. (RMTI)” was originally reported by Watch List News and is owned by of Watch List News. If you are reading this piece on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright law. The correct version of this piece can be viewed at https://www.watchlistnews.com/the-manufacturers-life-insurance-company-has-308000-position-in-rockwell-medical-inc-rmti/1742720.html.

Rockwell Medical Company Profile

Rockwell Medical, Inc (Rockwell) is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The Company operates through the hemodialysis market segment, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceutical, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process.

Want to see what other hedge funds are holding RMTI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rockwell Medical, Inc. (NASDAQ:RMTI).

Institutional Ownership by Quarter for Rockwell Medical (NASDAQ:RMTI)

Receive News & Ratings for Rockwell Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rockwell Medical Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.